Please Wait.....
Report
Dermatological Drugs Market by Dermatological Diseases (Acne, Dermatitis, Psoriasis, Skin Cancer, and Others), Route of Administration (Oral, Parenteral, Topical), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2023-2028
Market Report I 2023-06-14 I 140 Pages I IMARC Group
The global dermatological drugs market size reached US$ 21.58 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 39.11 Billion by 2028, exhibiting a growth rate (CAGR) of 10.25% during 2023-2028. The rising prevalence of skin disorders, the increasing demand for cosmeceuticals, and the growing awareness among individuals about skin health represent some of the key factors driving the market.
Dermatological drugs are medications that are used to treat various skin conditions, including acne, psoriasis, eczema, rosacea, skin cancer, fungal infections, and other disorders affecting the skin, hair, and nails. These drugs can be applied topically, orally, or by injection, depending on the type of skin condition being treated. Topical dermatological drugs, including creams, ointments, gels, and sprays, are directly applied to the skin. They are most commonly used to treat localized skin conditions, such as acne or eczema. On the other hand, systemic dermatological drugs are taken orally or by injection and work by targeting the underlying cause of a skin condition. These drugs are often used to treat severe or widespread skin conditions, such as psoriasis. These products have both cosmetic and pharmaceutical properties, and they are designed to improve the overall health and appearance of the skin. Moreover, dermatological drugs are prescribed by dermatologists or other healthcare professionals with expertise in skin health, which is escalating their demand across the globe.
Dermatological Drugs Market Trends:
The market is primarily driven by the increasing prevalence of skin disorders such as psoriasis, eczema, acne, rosacea, and skin cancer. In addition, the rising geriatric population that is more susceptible to such ailments represents another major growth-inducing factor. Besides this, individuals are widely adopting cosmeceuticals, which are cosmetic products with pharmaceutical properties to improve the overall health and appearance of the skin. This, coupled with the growing awareness among individuals about the importance of maintaining healthy skin, is positively influencing the market growth. Patients are now more aware of seeking treatment for skin conditions, leading to an increase in the overall demand for dermatological drugs. Moreover, various technological advancements in drug delivery systems, such as transdermal patches, nanotechnology, and microneedles, are driving the growth of the dermatological drugs market. These new drug delivery systems improve the efficacy of drugs and enhance patient compliance. Furthermore, the rising disposable incomes of consumers, the growing popularity of over the counter (OTC) drugs and the increasing awareness regarding the available treatment options are some of the other factors creating a favorable market outlook across the globe.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global dermatological drugs market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on dermatological diseases, route of administration, and distribution channel.
Dermatological Diseases Insights:
Acne
Dermatitis
Psoriasis
Skin Cancer
Others
The report has provided a detailed breakup and analysis of the dermatological drugs market based on the dermatological diseases. This includes acne, dermatitis, psoriasis, skin cancer, and others. According to the report, psoriasis represented the largest segment.
Route of Administration Insights:
Oral
Parenteral
Topical
A detailed breakup and analysis of the dermatological drugs market based on the route of administration has also been provided in the report. This includes oral, parenteral, and topical. According to the report, parenteral accounted for the largest market share.
Distribution Channel Insights:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
The report has provided a detailed breakup and analysis of the dermatological drugs market based on the distribution channel. This includes hospital pharmacies, retail pharmacies, and online pharmacies. According to the report, hospital pharmacies represented the largest segment.
Regional Insights:
North America
United States
Canada
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for dermatological drugs. Some of the factors driving the North America dermatological drugs market included the growing prevalence of skin conditions, the rising awareness regarding appearance, and the escalating demand for cosmeceuticals.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global dermatological drugs market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include AbbVie Inc., Amgen Inc., Bausch Health Companies Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, GSK plc, LEO Pharma A/S (LEO Holding A/S), Novartis AG, Pfizer Inc., Sanofi S.A., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report:
How has the global dermatological drugs market performed so far, and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global dermatological drugs market?
What is the impact of each driver, restraint, and opportunity on the global dermatological drugs market?
What are the key regional markets?
Which countries represent the most attractive dermatological drugs market?
What is the breakup of the market based on dermatological diseases?
Which is the most attractive dermatological disease in the dermatological drugs market?
What is the breakup of the market based on the route of administration?
Which is the most attractive route of administration in the dermatological drugs market?
What is the breakup of the market based on distribution channel?
Which is the most attractive distribution channel in the dermatological drugs market?
What is the competitive structure of the global dermatological drugs market?
Who are the key players/companies in the global dermatological drugs market?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Dermatological Drugs Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Dermatological Diseases
6.1 Acne
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Dermatitis
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Psoriasis
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Skin Cancer
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast
7 Market Breakup by Route of Administration
7.1 Oral
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Parenteral
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Topical
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Distribution Channel
8.1 Hospital Pharmacies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Retail Pharmacies
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Online Pharmacies
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 Drivers, Restraints, and Opportunities
10.1 Overview
10.2 Drivers
10.3 Restraints
10.4 Opportunities
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 AbbVie Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Amgen Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Bausch Health Companies Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Bristol-Myers Squibb Company
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Eli Lilly and Company
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 GSK plc
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 LEO Pharma A/S (LEO Holding A/S)
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.8 Novartis AG
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Pfizer Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Sanofi S.A.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT AnalysisKindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Figure 1: Global: Dermatological Drugs Market: Major Drivers and Challenges
Figure 2: Global: Dermatological Drugs Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Dermatological Drugs Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Dermatological Drugs Market: Breakup by Dermatological Diseases (in %), 2022
Figure 5: Global: Dermatological Drugs Market: Breakup by Route of Administration (in %), 2022
Figure 6: Global: Dermatological Drugs Market: Breakup by Distribution Channel (in %), 2022
Figure 7: Global: Dermatological Drugs Market: Breakup by Region (in %), 2022
Figure 8: Global: Dermatological Drugs (Acne) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Dermatological Drugs (Acne) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Dermatological Drugs (Dermatitis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Dermatological Drugs (Dermatitis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Dermatological Drugs (Psoriasis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Dermatological Drugs (Psoriasis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Dermatological Drugs (Skin Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Dermatological Drugs (Skin Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Dermatological Drugs (Other Dermatological Diseases) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Dermatological Drugs (Other Dermatological Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Dermatological Drugs (Oral) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Dermatological Drugs (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Dermatological Drugs (Parenteral) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Dermatological Drugs (Parenteral) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Dermatological Drugs (Topical) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Dermatological Drugs (Topical) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Dermatological Drugs (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Dermatological Drugs (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Dermatological Drugs (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Dermatological Drugs (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Dermatological Drugs (Online Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Dermatological Drugs (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: North America: Dermatological Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: North America: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: United States: Dermatological Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: United States: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Canada: Dermatological Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Canada: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Asia-Pacific: Dermatological Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Asia-Pacific: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: China: Dermatological Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: China: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: Japan: Dermatological Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: Japan: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: India: Dermatological Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: India: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: South Korea: Dermatological Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: South Korea: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Australia: Dermatological Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Australia: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Indonesia: Dermatological Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Indonesia: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Others: Dermatological Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Others: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Europe: Dermatological Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Europe: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Germany: Dermatological Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Germany: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: France: Dermatological Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: France: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: United Kingdom: Dermatological Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: United Kingdom: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Italy: Dermatological Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Italy: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Spain: Dermatological Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Spain: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Russia: Dermatological Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Russia: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Others: Dermatological Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Others: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Latin America: Dermatological Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Latin America: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Brazil: Dermatological Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Brazil: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Mexico: Dermatological Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Mexico: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Others: Dermatological Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Others: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Middle East and Africa: Dermatological Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Middle East and Africa: Dermatological Drugs Market: Breakup by Country (in %), 2022
Figure 78: Middle East and Africa: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Global: Dermatological Drugs Industry: Drivers, Restraints, and Opportunities
Figure 80: Global: Dermatological Drugs Industry: Value Chain Analysis
Figure 81: Global: Dermatological Drugs Industry: Porter's Five Forces Analysis
Table 1: Global: Dermatological Drugs Market: Key Industry Highlights, 2022 & 2028
Table 2: Global: Dermatological Drugs Market Forecast: Breakup by Dermatological Diseases (in Million US$), 2023-2028
Table 3: Global: Dermatological Drugs Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
Table 4: Global: Dermatological Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 5: Global: Dermatological Drugs Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Dermatological Drugs Market: Competitive Structure
Table 7: Global: Dermatological Drugs Market: Key Players
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security